Detalles de la búsqueda
1.
Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic.
J Behav Med
; 47(3): 405-421, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38418709
2.
Factors associated with changes in exercise behaviors during the COVID-19 pandemic.
Cancer Causes Control
; 33(7): 939-950, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35554777
3.
A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker.
BMC Cancer
; 21(1): 510, 2021 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33957901
4.
Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study.
Int J Gynecol Cancer
; 24(9): 1583-9, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25254563
5.
Surgical-decision making in the setting of unsuspected N2 disease: a cost-effectiveness analysis.
J Thorac Dis
; 16(2): 1063-1073, 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38505073
6.
Pathways to lung cancer diagnosis among individuals who did not receive lung cancer screening: a qualitative study.
BMC Prim Care
; 24(1): 203, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37789288
7.
Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042).
Clin Cancer Res
; 29(18): 3641-3649, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37233987
8.
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors.
J Immunother Cancer
; 11(1)2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36669791
9.
Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions.
J Rural Health
; 38(4): 886-899, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35243690
10.
Replicative Instability Drives Cancer Progression.
Biomolecules
; 12(11)2022 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36358918
11.
Efficacy and Safety of Rociletinib Versus Chemotherapy in Patients With EGFR-Mutated NSCLC: The Results of TIGER-3, a Phase 3 Randomized Study.
JTO Clin Res Rep
; 2(2): 100114, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34589984
12.
Impact of the COVID-19 pandemic on exercise habits among cancer patients.
Res Sq
; 2021 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34580667
13.
MYBL2-Driven Transcriptional Programs Link Replication Stress and Error-prone DNA Repair With Genomic Instability in Lung Adenocarcinoma.
Front Oncol
; 10: 585551, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33489883
14.
Primary Pulmonary Carcinoid Tumor: A Long-term Single Institution Experience.
Am J Clin Oncol
; 41(1): 24-29, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26270444
15.
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC.
PLoS One
; 13(11): e0208097, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30481207
16.
Impact of a multivariate serum-based proteomic test on physician treatment recommendations for advanced non-small-cell lung cancer.
Curr Med Res Opin
; 33(6): 1091-1097, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28277859
17.
Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies.
J Clin Oncol
; 35(25): 2885-2892, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28493811
18.
Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group B.
J Natl Cancer Inst
; 94(4): 284-90, 2002 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-11854390
19.
SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay.
J Thorac Oncol
; 11(3): 420-5, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26725184
20.
The impact of a serum based proteomic mass spectrometry test on treatment recommendations in advanced non-small-cell lung cancer.
Curr Med Res Opin
; 29(5): 517-25, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23452275